ACM
CHRS icon

ADAR1 Capital Management’s Coherus Oncology CHRS Stock Holding History

ADAR1 Capital Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5K Hold
10,366
– – ﹤0.01% 277
2026
Q1 		$17.5K Hold
10,366
– – ﹤0.01% 306
2025
Q4 		$14.7K Hold
10,366
– – ﹤0.01% 270
2025
Q3 		$17K Hold
10,366
– – ﹤0.01% 215
2025
Q2 		$7.58K Buy
+10,366
New +$8.95K ﹤0.01% 206

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

ADAR1 Capital Management's CHRS Position: Q2 2026 in Review

ADAR1 Capital Management held its Coherus Oncology (CHRS) position steady in Q2 2026 at 10,366 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #277.

ADAR1 Capital Management first reported a position in CHRS in Q2 2025 and has held it in 5 quarters since. The position peaked at $17.5K in Q1 2026. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • ADAR1 Capital Management held 10,366 shares of Coherus Oncology worth $14.5K as of Q2 2026.
  • ADAR1 Capital Management left its Coherus Oncology share count unchanged in Q2 2026.
  • Coherus Oncology made up ﹤0.01% of ADAR1 Capital Management's portfolio in Q2 2026, its #277 holding.
  • ADAR1 Capital Management first reported a position in Coherus Oncology in Q2 2025 and has held it in 5 quarters since.
  • ADAR1 Capital Management's Coherus Oncology position peaked at $17.5K in Q1 2026.
  • 147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.